Literature DB >> 30093408

IL-1R signaling promotes STAT3 and NF-κB factor recruitment to distal cis-regulatory elements that regulate Il17a/f transcription.

Sarah K Whitley1, Anand Balasubramani2, Carlene L Zindl3, Ranjan Sen4, Yoichiro Shibata5, Gregory E Crawford5, Nathaniel M Weathington6, Robin D Hatton3, Casey T Weaver2,3.   

Abstract

Interleukin (IL)-1β plays a critical role in IL-6β- and transforming growth factor β (TGFβ)-initiated Th17 differentiation and induction of Th17-mediated autoimmunity. However, the means by which IL-1 regulates various aspects of Th17 development remain poorly understood. We recently reported that IL-1β enhances STAT3 phosphorylation via NF-κB-mediated repression of SOCS3 to facilitate Il17 transcription and Th17 differentiation, identifying an effect of IL-1 signaling on proximal events of STAT3 signaling. Here, we show that IL-1β promotes STAT3 binding to key cis-elements that control IL-17 expression. Additionally, we demonstrate that the IL-1-induced NF-κB factor RelA directly regulates the Il17a/f loci in cooperation with STAT3. Our findings reveal that IL-1 impacts both proximal signaling events and downstream interactions between transcription factors and cis-regulatory elements to promote Il17a/f transcription and Th17 differentiation.

Entities:  

Keywords:  DNA-protein interaction; NF-kappa B (NF-KB); STAT3; chromatin immunoprecipitation (ChiP); interleukin 1 (IL-1); interleukin 17A (IL-17 or IL-17A)

Mesh:

Substances:

Year:  2018        PMID: 30093408      PMCID: PMC6187645          DOI: 10.1074/jbc.RA118.002721

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5.

Authors:  Xiang-Ping Yang; Kamran Ghoreschi; Scott M Steward-Tharp; Jaime Rodriguez-Canales; Jinfang Zhu; John R Grainger; Kiyoshi Hirahara; Hong-Wei Sun; Lai Wei; Golnaz Vahedi; Yuka Kanno; John J O'Shea; Arian Laurence
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

2.  STAT3 regulates cytokine-mediated generation of inflammatory helper T cells.

Authors:  Xuexian O Yang; Athanasia D Panopoulos; Roza Nurieva; Seon Hee Chang; Demin Wang; Stephanie S Watowich; Chen Dong
Journal:  J Biol Chem       Date:  2007-02-03       Impact factor: 5.157

3.  c-Rel is crucial for the induction of Foxp3(+) regulatory CD4(+) T cells but not T(H)17 cells.

Authors:  Alexander Visekruna; Magdalena Huber; Anne Hellhund; Evita Bothur; Katharina Reinhard; Nadine Bollig; Nicole Schmidt; Thorsten Joeris; Michael Lohoff; Ulrich Steinhoff
Journal:  Eur J Immunol       Date:  2010-03       Impact factor: 5.532

4.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Authors:  Ivaylo I Ivanov; Brent S McKenzie; Liang Zhou; Carlos E Tadokoro; Alice Lepelley; Juan J Lafaille; Daniel J Cua; Dan R Littman
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

5.  IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells.

Authors:  Liying Guo; Gang Wei; Jinfang Zhu; Wei Liao; Warren J Leonard; Keji Zhao; William Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-29       Impact factor: 11.205

6.  Induction of interferon-gamma production in Th1 CD4+ T cells: evidence for two distinct pathways for promoter activation.

Authors:  J Yang; T L Murphy; W Ouyang; K M Murphy
Journal:  Eur J Immunol       Date:  1999-02       Impact factor: 5.532

7.  Loss of epithelial RelA results in deregulated intestinal proliferative/apoptotic homeostasis and susceptibility to inflammation.

Authors:  Kris A Steinbrecher; Eleana Harmel-Laws; Raquel Sitcheran; Albert S Baldwin
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

8.  Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling.

Authors:  Kamran Ghoreschi; Arian Laurence; Xiang-Ping Yang; Cristina M Tato; Mandy J McGeachy; Joanne E Konkel; Haydeé L Ramos; Lai Wei; Todd S Davidson; Nicolas Bouladoux; John R Grainger; Qian Chen; Yuka Kanno; Wendy T Watford; Hong-Wei Sun; Gérard Eberl; Ethan M Shevach; Yasmine Belkaid; Daniel J Cua; Wanjun Chen; John J O'Shea
Journal:  Nature       Date:  2010-10-21       Impact factor: 49.962

9.  A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.

Authors:  Caroline Sutton; Corinna Brereton; Brian Keogh; Kingston H G Mills; Ed C Lavelle
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

10.  IL-1 signaling modulates activation of STAT transcription factors to antagonize retinoic acid signaling and control the TH17 cell-iTreg cell balance.

Authors:  Rajatava Basu; Sarah K Whitley; Suniti Bhaumik; Carlene L Zindl; Trenton R Schoeb; Etty N Benveniste; Warren S Pear; Robin D Hatton; Casey T Weaver
Journal:  Nat Immunol       Date:  2015-02-02       Impact factor: 25.606

View more
  13 in total

1.  NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells.

Authors:  Charupong Saengboonmee; Chatchai Phoomak; Suangson Supabphol; Kyle R Covington; Oliver Hampton; Chaisiri Wongkham; Richard A Gibbs; Kazuo Umezawa; Wunchana Seubwai; Marie-Claude Gingras; Sopit Wongkham
Journal:  Life Sci       Date:  2020-10-07       Impact factor: 5.037

2.  BATF promotes group 2 innate lymphoid cell-mediated lung tissue protection during acute respiratory virus infection.

Authors:  Xiaopeng Wu; Moujtaba Y Kasmani; Shikan Zheng; Achia Khatun; Yao Chen; Wendy Winkler; Ryan Zander; Robert Burns; Elizabeth J Taparowsky; Jie Sun; Weiguo Cui
Journal:  Sci Immunol       Date:  2022-01-14

Review 3.  Interleukins in cancer: from biology to therapy.

Authors:  Daria Briukhovetska; Janina Dörr; Stefan Endres; Peter Libby; Charles A Dinarello; Sebastian Kobold
Journal:  Nat Rev Cancer       Date:  2021-06-03       Impact factor: 69.800

4.  CD28 Individual Signaling Up-regulates Human IL-17A Expression by Promoting the Recruitment of RelA/NF-κB and STAT3 Transcription Factors on the Proximal Promoter.

Authors:  Martina Kunkl; Marta Mastrogiovanni; Nicla Porciello; Silvana Caristi; Emanuele Monteleone; Stefano Arcieri; Loretta Tuosto
Journal:  Front Immunol       Date:  2019-04-24       Impact factor: 7.561

Review 5.  T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis.

Authors:  Martina Kunkl; Simone Frascolla; Carola Amormino; Elisabetta Volpe; Loretta Tuosto
Journal:  Cells       Date:  2020-02-19       Impact factor: 6.600

Review 6.  Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities.

Authors:  Gloria Pastor-Fernández; Isabel R Mariblanca; María N Navarro
Journal:  Cells       Date:  2020-09-07       Impact factor: 6.600

Review 7.  Interleukin-1 as Innate Mediator of T Cell Immunity.

Authors:  Bram Van Den Eeckhout; Jan Tavernier; Sarah Gerlo
Journal:  Front Immunol       Date:  2021-01-27       Impact factor: 7.561

Review 8.  Cytokines that Modulate the Differentiation of Th17 Cells in Autoimmune Uveitis.

Authors:  Kailei Guo; Xiaomin Zhang
Journal:  J Immunol Res       Date:  2021-03-16       Impact factor: 4.818

9.  Th17 cell master transcription factor RORC2 regulates HIV-1 gene expression and viral outgrowth.

Authors:  Tomas Raul Wiche Salinas; Yuwei Zhang; Daniele Sarnello; Alexander Zhyvoloup; Laurence Raymond Marchand; Augustine Fert; Delphine Planas; Manivel Lodha; Debashree Chatterjee; Katarzyna Karwacz; Sally Oxenford; Jean-Pierre Routy; David Irlbeck; Heather Amrine-Madsen; Petronela Ancuta; Ariberto Fassati
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-30       Impact factor: 11.205

10.  High fat diet-induced brain damaging effects through autophagy-mediated senescence, inflammation and apoptosis mitigated by ginsenoside F1-enhanced mixture.

Authors:  Jingang Hou; Byeongmin Jeon; Jongin Baek; Yeejin Yun; Daeun Kim; Boyoon Chang; Sungyeon Kim; Sunchang Kim
Journal:  J Ginseng Res       Date:  2021-04-16       Impact factor: 6.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.